Euglobulin lysis time

Euglobulin Lysis Time (ELT) is a laboratory test used to evaluate the fibrinolysis system, which is an essential component of the hemostasis process. Fibrinolysis is the breakdown of fibrin in blood clots, a critical step in preventing the growth of potentially harmful clots and in the repair of tissues. The ELT measures the time required for a clot to dissolve in a sample of blood plasma treated to remove most of the clotting factors except for the euglobulins, which are proteins involved in the clotting and fibrinolysis processes.

Procedure

The test begins with the preparation of a euglobulin fraction from the patient's plasma. This is achieved by adjusting the plasma's pH and adding a cold ethanol solution, which precipitates the euglobulins. The precipitate is then dissolved in a weak acid solution. After the addition of a small amount of calcium to trigger clotting, the solution is incubated at 37°C. The time from the addition of calcium to the dissolution of the clot is measured and reported as the euglobulin lysis time.

Clinical Significance

ELT is used to assess the balance between clot formation and dissolution in the body. An abnormally short ELT suggests an enhanced fibrinolytic activity, which can lead to excessive bleeding. Conversely, a prolonged ELT indicates reduced fibrinolytic activity, which can predispose to thrombosis. Conditions that may alter fibrinolytic activity include liver disease, certain types of cancer, and systemic disorders like Systemic Lupus Erythematosus (SLE).

Limitations

The ELT test has several limitations. It is sensitive to the conditions under which it is performed, including the precise method of euglobulin precipitation and the temperature of incubation. Variability in these factors can lead to inconsistent results. Furthermore, the ELT does not provide information on the specific components of the fibrinolytic system that may be dysfunctional.

Conclusion

While the Euglobulin Lysis Time offers valuable insights into the fibrinolytic balance within the body, its limitations necessitate the use of additional tests for a comprehensive evaluation of hemostatic and fibrinolytic functions. As research advances, more specific and reliable tests are being developed to assess these complex systems.